Vanda Pharmaceuticals logo

Vanda Pharmaceuticals Share Price Today

(NASDAQ: VNDA)

Vanda Pharmaceuticals share price is $5.13 & ₹446.15 as on 6 Mar 2025, 2.30 'hrs' IST

$5.13

0.32

(6.65%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Vanda Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Vanda Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vanda Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Vanda Pharmaceuticals share price movements

  • Today's Low: $4.79
    Today's High: $5.15

    Day's Volatility :6.99%

  • 52 Weeks Low: $3.71
    52 Weeks High: $6.75

    52 Weeks Volatility :45.04%

Vanda Pharmaceuticals (VNDA) Returns

PeriodVanda Pharmaceuticals Inc.Sector (Health Care)Index (Russel 2000)
3 Months
7.32%
3.7%
0.0%
6 Months
0.98%
-2.8%
0.0%
1 Year
31.2%
2.5%
0.0%
3 Years
-53.7%
12.9%
-11.6%

Vanda Pharmaceuticals (VNDA) Key Statistics

in dollars & INR

Previous Close
$4.81
Open
$4.79
Today's High
$5.15
Today's Low
$4.79
Market Capitalization
$314.9M
Today's Volume
$1.3M
52 Week High
$6.75
52 Week Low
$3.71
Revenue TTM
$190.9M
EBITDA
$-30.2M
Earnings Per Share (EPS)
$-0.19
Profit Margin
-8.59%
Quarterly Earnings Growth YOY
-0.96%
Return On Equity TTM
-3.02%

How to invest in Vanda Pharmaceuticals Stock (VNDA) from India?

It is very easy for Indian residents to invest directly in Vanda Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vanda Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vanda Pharmaceuticals or VNDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vanda Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vanda Pharmaceuticals shares which would translate to 0.170 fractional shares of Vanda Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vanda Pharmaceuticals, in just a few clicks!

Returns in Vanda Pharmaceuticals (VNDA) for Indian investors in Rupees

The Vanda Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vanda Pharmaceuticals investment value today

Current value as on today

₹1,36,151

Returns

₹36,151

(+36.15%)

Returns from Vanda Pharmaceuticals Stock

₹31,202 (+31.2%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Vanda Pharmaceuticals (VNDA)

24%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Vanda Pharmaceuticals Stock from India on INDmoney has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vanda Pharmaceuticals

  • BlackRock Inc

    15.61%

  • Renaissance Technologies Corp

    6.61%

  • Vanguard Group Inc

    6.01%

  • Dimensional Fund Advisors, Inc.

    4.27%

  • TANG CAPITAL MANAGEMENT LLC

    4.04%

  • Geode Capital Management, LLC

    2.49%

Analyst Recommendation on Vanda Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Vanda Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
0
0
Hold
1
3
3
Sell
0
3
3

Analyst Forecast on Vanda Pharmaceuticals Stock (VNDA)

What analysts predicted

Upside of 103.31%

Target:

$10.43

Current:

$5.13

Insights on Vanda Pharmaceuticals Stock (Ticker Symbol: VNDA)

  • Price Movement

    In the last 7 days, VNDA stock has moved up by 9.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 47.65M → 53.18M (in $), with an average increase of 10.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -5.32M → -4.91M (in $), with an average increase of 8.4% per quarter
  • VNDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 35.3%
  • VNDA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 104.3%
  • Price to Sales

    ForVNDA every $1 of sales, investors are willing to pay $1.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Vanda Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Vanda Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Vanda Pharmaceuticals (VNDA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vanda Pharmaceuticals Inc. logo
14.51%
0.98%
31.2%
-53.7%
-48.18%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vanda Pharmaceuticals Inc. logo
126.0
NA
-2.42
-0.32
-0.03
-0.04
NA
9.28
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vanda Pharmaceuticals Inc. logo
Buy
$314.9M
-48.18%
126.0
-8.59%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) a LAI formulation to treat schizophrenia; Bysanti for the acute treatment of bipolar I disorder, schizophrenia, and major depressive disorder; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, and atopic dermatitis. The company's pipeline products also include Imsidolimab, an IL-36R antagonist, for the treatment of generalized pustular psoriasis; VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; VPO-227 for the treatment of secretory diarrhea disorders comprising cholera; Antisense oligonucleotide molecules, including VCA-894A for the treatment of Charcot-Marie-Tooth Disease and Type 2S (CMT2S); and VGT-1849A for the treatment of polycythemia vera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Organization
Vanda Pharmaceuticals
Employees
368
CEO
Dr. Mihael H. Polymeropoulos M.D.
Industry
Health Technology

Management People of Vanda Pharmaceuticals

NameTitle
Dr. Mihael H. Polymeropoulos M.D.
Founder, President, CEO & Chairman of The Board
Mr. Kevin Patrick Moran
Senior VP, CFO & Treasurer
Mr. Timothy Williams J.D.
Senior VP, General Counsel & Secretary
Mr. Joakim Wijkstrom
Senior VP & Chief Marketing Officer
Mr. Gunther Birznieks
Senior Vice President of Business Development
Mr. Scott L. Howell
Chief People Officer

Important FAQs about investing in VNDA Stock from India :

What is Vanda Pharmaceuticals share price today?

Vanda Pharmaceuticals share price today stands at $5.13, Open: $4.79 ; Previous Close: $4.81 ; High: $5.15 ; Low: $4.79 ; 52 Week High: $6.75 ; 52 Week Low: $3.71.

The stock opens at $4.79, after a previous close of $4.81. The stock reached a daily high of $5.15 and a low of $4.79, with a 52-week high of $6.75 and a 52-week low of $3.71.

Can Indians buy Vanda Pharmaceuticals shares?

Yes, Indians can invest in the Vanda Pharmaceuticals (VNDA) from India.

With INDmoney, you can buy Vanda Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vanda Pharmaceuticals at zero transaction cost.

How can I buy Vanda Pharmaceuticals shares from India?

It is very easy to buy Vanda Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vanda Pharmaceuticals (VNDA) be purchased?

Yes, you can buy fractional shares of Vanda Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Vanda Pharmaceuticals stocks?

To start investing in Vanda Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vanda Pharmaceuticals Stock (VNDA)?

Today’s highest price of Vanda Pharmaceuticals (VNDA) is $5.15.

Today’s lowest price of Vanda Pharmaceuticals (VNDA) is $4.79.

What is today's market capitalisation of Vanda Pharmaceuticals?

Today's market capitalisation of Vanda Pharmaceuticals VNDA is 314.9M

What is the 52 Week High and Low Range of Vanda Pharmaceuticals Stock (VNDA)?

  • 52 Week High

    $6.75

  • 52 Week Low

    $3.71

What are the historical returns of Vanda Pharmaceuticals (VNDA)?

  • 1 Month Returns

    14.51%

  • 3 Months Returns

    0.98%

  • 1 Year Returns

    31.2%

  • 5 Years Returns

    -48.18%

Who is the Chief Executive Officer (CEO) of Vanda Pharmaceuticals ?

Dr. Mihael H. Polymeropoulos M.D. is the current Chief Executive Officer (CEO) of Vanda Pharmaceuticals.